Literature DB >> 2312677

Tuberculous anergic sera or purified protein derivative treatment induces modification in lymphocyte transformation of cells from patients with tuberculosis.

H Mejia-López1, O Vaca-García, J M Cristerna-Aguirre, A Cruz-Chávez, M Selman-Lama, M L Taylor.   

Abstract

Peripheral blood mononuclear cells from 20 purified protein derivative (PPD)-reactive (PPD+) tuberculous patients were cultured in autologous, tuberculous anergic, or normal serum. After 12 h of incubation, the serum was eliminated and lymphocyte transformation with PPD was performed. Transformation was inhibited only in cells incubated with anergic serum. In contrast, cells from 11 anergic tuberculous (PPD-) individuals recovered the ability to respond to an optimal PPD dose after treatment with high PPD concentrations followed by several washings. The cells which recovered returned to their initial anergic state when incubated with sera from anergic patients. Under both conditions, incubation with sera did not abolish the response to the mitogen phytohemagglutinin. Cells from healthy PPD+ or PPD- individuals were used as controls. The most important finding derived from serum analysis was the increased levels of specific immunoglobulins G and A in anergic patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312677      PMCID: PMC269604          DOI: 10.1128/jcm.28.2.344-349.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Mouse serum factor depressing lymphocyte transformation.

Authors:  D S Nelson
Journal:  Experientia       Date:  1972-10-15

3.  Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis.

Authors:  W M Newberry; J W Chandler; T D Chin; C H Kirkpatrick
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

4.  Spectrum of immune response abnormalities in different clinical forms of tuberculosis.

Authors:  R Bhatnagar; A N Malaviya; S Narayanan; P Rajgopalan; R Kumar; O P Bharadwaj
Journal:  Am Rev Respir Dis       Date:  1977-02

5.  Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response.

Authors:  W E Bullock; P Fasal
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

6.  Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors.

Authors:  D H Heilman; W McFarland
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

7.  Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.

Authors:  G Bjune; R S Barnetson; D S Ridley; G Kronvall
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

8.  Circulating T-cell numbers and their mitogenic potential in leprosy--correlation with mycobacterial load.

Authors:  I Nath; J Curtis; A K Sharma; G P Talwar
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

9.  The spectrum of human tuberculosis.

Authors:  L Lenzini; P Rottoli; L Rottoli
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

10.  Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.

Authors:  D S Nelson; J M Penrose; M F Waters; J M Pearson; M Nelson
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.